Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Number of holders
-
524
-
Total 13F shares, excl. options
-
666,718,989
-
Shares change
-
-3,744,974
-
Total reported value, excl. options
-
$16,214,840,524
-
Value change
-
-$65,167,761
-
Put/Call ratio
-
124%
-
Number of buys
-
257
-
Number of sells
-
202
-
Price
-
$24.32
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2018
As of 30 Jun 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 524 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 666,718,989 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, FRANKLIN RESOURCES INC, Berkshire Hathaway Inc, Capital World Investors, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, HIGHFIELDS CAPITAL MANAGEMENT LP, Northern Cross, LLC, FMR LLC, and ABRAMS CAPITAL MANAGEMENT, L.P..
This table shows 524 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.